The 28 references in paper I. Kayukov G., A. Smirnov V., A. Kucher G., M. Parastaeva M., O. Beresneva N., M. Zaraiskii I., C. Ivanova T., И. Каюков Г., А. Смирнов В., А. Кучер Г., М. Парастаева М., О. Береснева Н., М. Зарайский И., Г. Иванова Ю. (2017) “ЭКСПРЕССИЯ микроРНК-21 В ПОЧЕЧНОЙ ТКАНИ И МОЧЕ У КРЫС С ОДНОСТОРОННЕЙ ОБСТРУКЦИЕЙ МОЧЕТОЧНИКА // EXPRESSION miRNA-21 IN RENAL TISSUE AND URINE IN RATS WITH UNILATERAL URETERAL OBSTUCTION” / spz:neicon:nefr:y:2017:i:1:p:46-51

1
Kataoka M, Wang DZ. Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells 2014; 3(3): 883-898
(check this in PDF content)
2
Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol 2014; 63(21): 2177-2187
(check this in PDF content)
3
Gharipour M, Sadeghi M. Pivotal role of microRNA-33 in metabolic syndrome: A systematic review. ARYA Atheroscler 2013; 9(6): 372-376
(check this in PDF content)
4
Смирнов АВ, Кучер АГ, Добронравов ВА и др. Диетарный соевый протеин замедляет развитие интерстициального почечного фиброза у крыс с односторонней обструкцией мочеточника: введение в нутритивную эпигеномику. Нефрология 2012; 16(4):75-83 [Smirnov AV, Kucher AG, Dobronravov VA i dr. Dietarnyi soevyi protein zamedljаet razvitie intersticial’nogo pochechnogo fibroza u krys s odnostoronnei obstrukciei mochetochnika: vvedenie v nutritivnuyu yеpigenomiku. Nefrologijа 2012; 16(4):75-83]
(check this in PDF content)
5
Adams BD, Kasinski AL, Slack FJ. Aberrant Regulation and Function of MicroRNAs in Cancer. Curr Biol 2014; 24(16): R762-R776
(check this in PDF content)
6
Qingqing W, Qing-Sheng M, Zheng D. The regulation and function of microRNAs in kidney diseases. IUBMB Life 2013; 65(7): 602–614
(check this in PDF content)
7
Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-157
(check this in PDF content)
8
Landgraf P, Rusu M, Sheridan R et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129(7): 1401-1414
(check this in PDF content)
9
Sun Y, Koo S, White N et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 2004; 32(22): e188
(check this in PDF content)
10
Chandrasekaran K, Karolina DS, Sepramaniam S et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012; 81(7): 617-627
(check this in PDF content)
11
Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol 2011; 8(5): 706–713
(check this in PDF content)
12
Lan HY. Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation. Int J Biol Sci 2011; 7(7): 1056–1067
(check this in PDF content)
13
Duffield JS, Grafals M, Portilla D. MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal models. Drug Discov Today Dis Models 2013; 10(3):e127-e135
(check this in PDF content)
14
Patel V, Noureddine L. MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 2012; 21(4): 410–416
(check this in PDF content)
15
Zarjou A, Yang S, Abraham E,Agarwal A et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol 2011; 301(4): F793–F801
(check this in PDF content)
16
Береснева ОН, Парастаева ММ, Иванова ГТ и др. Влияние метформина на формирование тубулоинтерстициального фиброза у крыс. Нефрология 2014; 19(6): 45-48 [Beresneva ON, Parastaeva MM, Ivanova GT i dr. Vlijаnie metformina na formirovanie tubulointersticial’nogo fibroza u krys. Nefrologijа 2014; 19(6): 45-48]
(check this in PDF content)
17
Chung AC, Lan HY. MicroRNAs in renal fibrosis. Front Physiol 2015; 6:50. doi: 10.3389/fphys.2015.00050
(check this in PDF content)
18
Cмирнов АВ, Карунная АВ, Зарайский МИ и др. Экспрессия микроРНК-21 в моче у пациентов с нефропатиями. Нефрология 2014; 18(6): 59-63 [Smirnov AV, Karunnaya AV, Zarayskiy MI i dr. Ekspressiya mikroRNK-21 v moche u patsientov s nefropatiyami. Nefrologiya 2014; 18(6): 59-63]
(check this in PDF content)
19
D’Alessandra Y, Devanna P, Limana F et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31(22): 2765–2773
(check this in PDF content)
20
Shi B, Guo Y, Wang J, Gao W. Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovasc Disord 2010; 10:11
(check this in PDF content)
21
Godwin JG, Ge X, Stephan K et al. Identification of a microRNA signature of renal ischemia–reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339–14344
(check this in PDF content)
22
Thum T, Gross C, Fiedler J et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980–984
(check this in PDF content)
23
Liu G, Friggeri A, Yang Y et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010; 207: 1589–1597
(check this in PDF content)
24
Zhong X, Chung AC, Chen HY et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22: 1668–1681
(check this in PDF content)
25
Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309-320
(check this in PDF content)
26
Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005;10(1):48-56
(check this in PDF content)
27
Смирнов АВ, Иванова ГТ, Береснева ОН и др. Экспериментальная модель интерстициального почечного фиброза. Нефрология 2009; 13(4): 70-74 [Smirnov AV, Ivanova GT, Beresneva ON i dr. Yeksperimental’najа model’ intersticial’nogo pochechnogo fibroza. Nefrologijа 2009; 13(4): 70-74]
(check this in PDF content)
28
Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008;454:56–61 Сведения об авторах: Проф. Каюков Иван Глебович
(check this in PDF content)